Semax vs Selank: Research, Routes & Safety Comparison
Compare Semax and Selank by category, route, half-life, molecular weight, approval status, reported effects, and educational safety context.
Side-by-side comparison table
Core database fields for comparing the two peptide profiles.
Comparison context
Why these two peptides are compared
These peptides are often compared because both are discussed in cognition, stress, and nootropic contexts. The comparison should stay cautious because U.S. approval status is limited.
The goal is to make the comparison easier to inspect before opening the full profiles, not to tell readers which peptide is better, safer, stronger, or appropriate.
Main similarity
What overlaps
Both are listed as nasal mind-category peptides and not FDA-approved in the U.S.
Main difference
What separates them
Semax is described as an ACTH(4-10) analog with cognitive and neuroprotective research context, while Selank is described as a tuftsin analog with anxiolytic and nootropic research context.
Evidence summary
How to read this comparison
This page compares database fields only. It does not rank which peptide is better, safer, stronger, or appropriate for any person.
Evidence strength can differ by molecule and indication. FDA-approved status, investigational status, cosmetic use, animal research, and in vitro research should not be treated as equivalent evidence.
Evidence comparison
Evidence strength and limitations
Mind and cognition claims can outpace evidence. Peptidic keeps the page focused on research context, approval status, and source review rather than promising cognitive outcomes.
Both are listed as not FDA-approved in the U.S. That approval context should be kept separate from regional use or research discussion.
Route comparison
Route, half-life, and format
Both entries are nasal, so formulation and regional research context matter more than simply sharing the same route label.
Half-life also differs across molecules and formulations. Compare half-life with molecular weight, approval status, and source links instead of converting it directly into a personal schedule.
Peptidic tools
Which tools help with this comparison
Use the mind category hub for nearby entries and the profile source sections for deeper review before comparing reported effects.
The calculator explains unit math, the tracker organizes private records, and the database/profile pages provide public reference fields. None of these tools replace approved labeling or qualified professional guidance.
Frequently asked questions
Why compare Semax and Selank?
These peptides are often compared because both are discussed in cognition, stress, and nootropic contexts. The comparison should stay cautious because U.S. approval status is limited.
What is the main difference between Semax and Selank?
Semax is described as an ACTH(4-10) analog with cognitive and neuroprotective research context, while Selank is described as a tuftsin analog with anxiolytic and nootropic research context.
Can this comparison be used to choose a peptide?
No. Comparison pages are educational references only and are not treatment, dosing, sourcing, or personal-use recommendations.
Where can I review the full profiles?
Use the profile links on this page to open the full Semax and Selank pages, including overview text, source links where available, and related peptide links.